Results 231 to 240 of about 231,777 (344)

Thyroid hormone effects on androgen receptor messenger RNA expression in rat Sertoli and peritubular cells [PDF]

, 1998
NK Arambepola, David Bunick, PS Cooke
openalex   +1 more source

Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs Mutation

The Prostate, EarlyView.
ABSTRACT Background Methyl Methanesulfonate‐Sensitivity Protein 22‐Like (MMS22L) plays a key role in homology‐directed DNA repair, and experimental models have shown that its loss confers sensitivity to Poly (ADP‐ribose) polymerase inhibitors (PARPi).
Mayuko Kanayama, Violet A. Daniels, Marta Gielzak, Alex Brame, Misop Han, Li Jia, Jianfeng Xu, Tamara L. Lotan, Mario A. Eisenberger, Catherine H. Marshall, Patrick C. Walsh, William B. Isaacs, Jun Luo   +12 more
wiley   +1 more source

Coregulators determine androgen receptor activity in prostate cancer. [PDF]

Biosci Rep
Yavuz K, Lack NA.
europepmc   +1 more source

Genomic and Clinical Impact of Smoking on Therapeutic Outcomes in Prostate Cancer: A Public Databases Analysis

The Prostate, EarlyView.
ABSTRACT Background In prostate cancer (PCa), smoking history is associated with more aggressive clinicopathological features, reduced efficacy of androgen deprivation therapy, and poorer overall survival (OS). However, its impact on survival outcomes in patients receiving taxane chemotherapy, poly ADP‐ribose polymerase inhibitor (PARPi), or immune ...
Tomoya Hatayama, Yohei Sekino, Go Kobayashi, Kazuma Yukihiro, Yoshinori Nakano, Shinsaku Tasaka, Naofumi Nomura, Yuki Kohada, Kenshiro Takemoto, Miki Naito, Shunsuke Miyamoto, Kohei Kobatake, Hiroyuki Kitano, Keisuke Goto, Akihiro Goriki, Keisuke Hieda, Nobuyuki Hinata   +16 more
wiley   +1 more source

Androgen receptor-mediated regulation of BRCA1 modulates the antioxidant defense in prostate cancer. [PDF]

J Pathol
Sriraman S, Virtanen V, Kukkula A, Toriseva M, Lumiainen A, West G, Poutanen M, Taimen P, Sundvall M.   +8 more
europepmc   +1 more source

Juvenile nasopharyngeal fibroma: Androgen receptors and their significance for tumor growth [PDF]

, 1994
Rudolf Hagen, Gabriela Romalo, Burkard Schwab, Florian Hoppe, Hans‐Udo Schweikert   +4 more
openalex   +1 more source

A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 495-509, March 2025.
Abstract Patients with recurrent high‐grade glioma (rHGG) have a poor prognosis with median progression‐free survival (PFS) of <7 months. Responses to treatment are heterogenous, suggesting a clinical need for prognostic models. Bayesian data analysis can exploit individual patient follow‐up imaging studies to adaptively predict the risk of progression.
Daniel J. Glazar, Solmaz Sahebjam, Hsiang‐Husan M. Yu, Dung‐Tsa Chen, Menal Bhandari, Heiko Enderling   +5 more
wiley   +1 more source

Correction: Adverse events of androgen receptor pathway inhibitors in prostate cancer from real world data. [PDF]

PLoS One
Lee J, Song M, Leem S, Kim JY, Shim SR, Kim JH, Chung BI.   +6 more
europepmc   +1 more source

Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. [PDF]

, 1991
Michael J. McPhaul, Marco Marcelli, Wayne D. Tilley, Jim E. Griffin, ROSARIO F. ISIDRO-GUTIERREZ, Jean D. Wilson   +5 more
openalex   +1 more source

Evaluation of Potential Hormonal Activities of Ashwagandha (Withania somnifera)

Phytotherapy Research, EarlyView.
ABSTRACT Ashwagandha is a widely used herb in traditional medicine systems, particularly Ayurveda. Despite its extensive tradition, growing concerns regarding its potential endocrinological effects have prompted scientific scrutiny. This review systematically evaluates the current preclinical, clinical, and case study evidence concerning AS's effects ...
Günter Vollmer, Thomas Brendler
wiley   +1 more source